Moreover, CD4(+) T cells from SLE patients displayed enhanced glycolysis and mitochondrial metabolism correlating with their activation status, and metformin significantly reduced their excessive IFN-g production in vitro. This evidence concerns the gene CD4 and systemic lupus erythematosus.